SCP-3262
Safe
~
medium confidence
SCP-3262
Expected annual
$270K
One-time setup
$1.2M
Annual recurring
$252K
Personnel
4
One-time setup costs total approximately $1.19M driven mainly by a contingency scale-up/containment build and site/lab fit-outs; recurring annual costs are ~ $251.7k/year driven by staff wages (researcher, security, caregiver), research/testing, and emergency/readiness reserves.
One-Time Capital Costs
Total: $1.2M
Annual Recurring Costs
Total: $252K/yr
Cost Scenarios
📊
Baseline
(baseline)
$252K/yr
Routine year with occasional testing, immediate termination of specimens, and no major incidents.
occasional characterization tests
no containment incidents
standard staff operations
🚨
Minor Incident
$302K/yr
Small containment event or localized discovery requiring extra quarantine, disposal, and legal/response expenses.
localized contamination
unexpected specimen retention
small public exposure or FOIA pressure
🚨
Major Breach
$1.0M/yr
Significant containment breach or misuse leading to broad quarantine, intensive medical and security response, and site-level disruption.
escape or public exposure
multiple uncontrolled specimens
extended site lockdown
🚨
Research Scale Up
$1.5M/yr
Deliberate or accidental scale-up to retain and study multiple specimens long-term requiring specialized wards and significant staffing.
policy decision to study specimens long-term
accidental/proliferative mass-production
programmatic expansion
Personnel
4 total
| Role | Count | Notes |
|---|---|---|
| Research Scientist | 1 | [#4] One Level-2+ researcher allocated on a part-time basis (0.1–0.25 FTE); cost pro-rated into staff wages. |
| Security Officer / MTF Agent | 2 | [#5] Two guards required during active testing/transfers for physical control and escort; costs included in staff wages. |
| Caregiver / Technician | 1 | [#10] One part-time technician/caregiver for short-term specimen housing and care; wages and consumables budgeted. |
Confidence Notes
Analyst notes provide detailed line items and ranges enabling mid-range estimates, but several items (scale-up contingency, frequency of testing, outsourcing vs. instrument purchase) are uncertain, so confidence is medium.